NO20012223D0 - Nukleotid og proteinsekvenser for NOGO-gener og fremgangsmåter basert derpå - Google Patents

Nukleotid og proteinsekvenser for NOGO-gener og fremgangsmåter basert derpå

Info

Publication number
NO20012223D0
NO20012223D0 NO20012223A NO20012223A NO20012223D0 NO 20012223 D0 NO20012223 D0 NO 20012223D0 NO 20012223 A NO20012223 A NO 20012223A NO 20012223 A NO20012223 A NO 20012223A NO 20012223 D0 NO20012223 D0 NO 20012223D0
Authority
NO
Norway
Prior art keywords
nucleotide
protein sequences
methods based
nogo
nogo genes
Prior art date
Application number
NO20012223A
Other languages
English (en)
Other versions
NO20012223L (no
NO332460B1 (no
Inventor
Martin E Schwab
Maio S Chen
Original Assignee
Martin E Schwab
Maio S Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22316666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20012223(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Martin E Schwab, Maio S Chen filed Critical Martin E Schwab
Publication of NO20012223D0 publication Critical patent/NO20012223D0/no
Publication of NO20012223L publication Critical patent/NO20012223L/no
Publication of NO332460B1 publication Critical patent/NO332460B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NO20012223A 1998-11-06 2001-05-04 Renset humant NOGO protein, fusjon- eller kimaert protein, isolert nukleinsyre, kloningsvektor, rekombinant celle, fremgangsmate for fremstilling av proteinet, samt anvendelse av proteinet for fremstilling av et medikament for behandling. NO332460B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10744698P 1998-11-06 1998-11-06
PCT/US1999/026160 WO2000031235A2 (en) 1998-11-06 1999-11-05 Nucleotide and protein sequences of nogo genes and methods based thereon

Publications (3)

Publication Number Publication Date
NO20012223D0 true NO20012223D0 (no) 2001-05-04
NO20012223L NO20012223L (no) 2001-07-02
NO332460B1 NO332460B1 (no) 2012-09-24

Family

ID=22316666

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012223A NO332460B1 (no) 1998-11-06 2001-05-04 Renset humant NOGO protein, fusjon- eller kimaert protein, isolert nukleinsyre, kloningsvektor, rekombinant celle, fremgangsmate for fremstilling av proteinet, samt anvendelse av proteinet for fremstilling av et medikament for behandling.

Country Status (27)

Country Link
US (4) US7781188B1 (no)
EP (3) EP2333064A1 (no)
JP (2) JP2003531566A (no)
KR (1) KR100728405B1 (no)
CN (3) CN1721444A (no)
AT (1) ATE435232T1 (no)
AU (1) AU774367C (no)
BR (1) BR9915137A (no)
CA (1) CA2350395C (no)
CY (1) CY1110679T1 (no)
CZ (1) CZ304224B6 (no)
DE (1) DE69941059D1 (no)
DK (1) DK1124846T3 (no)
ES (2) ES2529196T3 (no)
HK (1) HK1038027A1 (no)
HU (1) HUP0301829A3 (no)
IL (3) IL142989A0 (no)
MX (1) MXPA01004598A (no)
NO (1) NO332460B1 (no)
NZ (1) NZ511683A (no)
PL (1) PL204293B1 (no)
PT (1) PT1124846E (no)
RU (3) RU2304585C2 (no)
SK (1) SK287323B6 (no)
TR (1) TR200700740T2 (no)
WO (1) WO2000031235A2 (no)
ZA (1) ZA200103714B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020072493A1 (en) * 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
PT1098972E (pt) * 1998-07-22 2010-12-14 Smithkline Beecham Ltd Proteína semelhante a proteína especificamente neuroendócrina e adnc codificante
US7781188B1 (en) 1998-11-06 2010-08-24 University Of Zurich Nucleotide and protein sequences of Nogo genes and methods based thereon
US7186530B1 (en) 2000-04-07 2007-03-06 Chiron Corporation Protein associated with cell stress response
WO2000060083A1 (en) * 1999-04-08 2000-10-12 Chiron Corporation Novel protein associated with cell stress response
CZ20022438A3 (cs) * 2000-01-12 2002-10-16 Yale University Nukleová kyselina kódující receptor Nogo, izolovaný polypeptid a farmaceutický přípravek pro stimulaci růstu axonů
US7119165B2 (en) * 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
US7049395B2 (en) 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
ATE458815T1 (de) 2000-10-06 2010-03-15 Univ Yale Homologe des nogo rezeptors
GB0101312D0 (en) * 2001-01-18 2001-02-28 Glaxo Group Ltd Assay
GB0101313D0 (en) * 2001-01-18 2001-02-28 Glaxo Group Ltd Assay
AR040778A1 (es) 2002-08-06 2005-04-20 Glaxo Group Ltd Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina).
GB0228832D0 (en) 2002-12-10 2003-01-15 Novartis Ag Organic compound
US20060287501A1 (en) * 2002-10-31 2006-12-21 Pieris Proteolab Ag Soluble truncated polypeptides of the nogo-a protein
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
RS54160B1 (sr) 2003-03-19 2015-12-31 Biogen Idec Ma Inc. Protein koji se vezuje za nogo receptor
TWI329649B (en) * 2003-12-22 2010-09-01 Glaxo Group Ltd Immunoglobulins
CA2572193A1 (en) 2004-06-24 2006-01-05 Biogen Idec Ma Inc. Treatment of conditions involving oligodendrocytes with sp35 based agents
KR100659820B1 (ko) 2004-11-17 2006-12-19 삼성에스디아이 주식회사 리튬 이온 이차 전지
SG157418A1 (en) * 2004-12-01 2009-12-29 Univ Singapore Nogo a protein fragments as neuronal network- interacting peptides
WO2007008732A2 (en) 2005-07-07 2007-01-18 Yale University Compositions and methods for suppressing axonal growth inhibition
EP2238986A3 (en) 2005-07-08 2010-11-03 Biogen Idec MA Inc. Sp35 antibodies and uses thereof
WO2007014382A1 (en) * 2005-07-28 2007-02-01 Wyeth Compositions and methods of mutant nogo-66 domain proteins
KR20080073748A (ko) 2005-11-16 2008-08-11 노파르티스 아게 척수 손상에서의 항-ｎｏｇｏ-ａ 항체 치료를 위한바이오마커
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
CA2653456A1 (en) * 2006-05-24 2007-11-29 Richard Daneman Permeability of blood-brain barrier
CN101015683B (zh) * 2007-01-18 2010-07-21 复旦大学 人rtn4b蛋白在制备创伤愈合药物中的应用
BRPI0818928B1 (pt) * 2007-11-02 2021-12-07 Novartis Ag Moléculas de ligação a nogo-a isoladas, seu método de produção e seu uso, polinucleotídeo isolado, vetor e sistema de expressão, célula hospedeira isolada, e composição farmacêutica
US20090186423A1 (en) * 2007-11-22 2009-07-23 Symphogen A/S Method for Characterization of a Recombinant Polyclonal Protein
AU2009269099B2 (en) 2008-07-09 2016-03-10 Biogen Ma Inc. Compositions comprising antibodies to LINGO or fragments thereof
AU2010256880B2 (en) * 2009-06-02 2015-01-22 Opko Health, Inc. Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
US8828390B2 (en) 2010-07-09 2014-09-09 Universitat Zurich Uses of NOGO-A inhibitors and related methods
RU2478646C1 (ru) * 2011-11-28 2013-04-10 Федеральное государственное бюджетное учреждение науки Институт молекулярной биологии им.В.А.Энгельгардта Российской академии наук (ИМБ РАН) Способ получения высокоаффинных поликлональных антител
JP2015518829A (ja) 2012-05-14 2015-07-06 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 運動ニューロンに関する状態の処置のためのｌｉｎｇｏ−２アンタゴニスト
EA032285B1 (ru) * 2013-08-08 2019-05-31 Глобал Био Терапьютикс, Инк. Прибор для инъекций с минимальным захватом и его использование
KR101685109B1 (ko) * 2014-12-22 2016-12-09 경북대학교 산학협력단 근육 분화, 재생, 또는 질환 상태와 관련된 노고-에이의 용도
CA2973266A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
US20180015144A1 (en) * 2015-01-27 2018-01-18 Universitat Zurich Agonists of the nogo-a s1pr pathway for the treatment of glioblastoma

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
CA1173823A (en) 1980-08-26 1984-09-04 Leonard M. Hjelmeland Nondenaturing zwitterionic detergent for membrane biochemistry
EP0155433A1 (en) 1984-03-23 1985-09-25 Adriano Fontana Immunosuppressant factor
CA1341401C (en) 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
EP0233838A3 (en) 1986-02-04 1990-01-31 Incyte Pharmaceuticals, Inc. Neurite-promoting factor and process for the manufacture thereof
DE68927438T2 (de) 1988-06-13 1997-03-20 American Biogenetic Sciences Verfahren zur herstellung monoklonaler antikörper mit hilfe eines keimfreien tieres
US5250414A (en) 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
CA1341050C (en) * 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
EP0396719B1 (en) 1988-11-04 1995-07-05 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
WO1993000427A2 (en) * 1991-06-24 1993-01-07 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
US5858708A (en) * 1996-08-12 1999-01-12 Bandman; Olga Polynucleotides encoding two novel human neuroendocrine-specific proteins
WO1998017687A2 (en) * 1996-10-25 1998-04-30 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
EP1042470A2 (en) * 1997-12-30 2000-10-11 Chiron Corporation Bone marrow secreted proteins and polynucleotides
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US20020072493A1 (en) * 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
PT1098972E (pt) 1998-07-22 2010-12-14 Smithkline Beecham Ltd Proteína semelhante a proteína especificamente neuroendócrina e adnc codificante
EP1107978A1 (en) * 1998-08-24 2001-06-20 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
US7781188B1 (en) 1998-11-06 2010-08-24 University Of Zurich Nucleotide and protein sequences of Nogo genes and methods based thereon
WO2001036631A1 (en) * 1999-11-15 2001-05-25 Smithkline Beecham P.L.C. Human nogo-c polynucleotide and polypeptide and their uses
US20030134301A1 (en) * 2001-07-27 2003-07-17 Brooksbank Robert Alan Identification and use of molecules implicated in pain

Also Published As

Publication number Publication date
CA2350395C (en) 2014-07-08
SK6222001A3 (en) 2001-12-03
ES2529196T3 (es) 2015-02-17
CN1721444A (zh) 2006-01-18
AU1469200A (en) 2000-06-13
ES2329635T3 (es) 2009-11-27
HUP0301829A2 (hu) 2003-08-28
BR9915137A (pt) 2004-06-08
RU2009103533A (ru) 2010-11-10
NO20012223L (no) 2001-07-02
CA2350395A1 (en) 2000-06-02
CN101684155A (zh) 2010-03-31
US7781188B1 (en) 2010-08-24
ATE435232T1 (de) 2009-07-15
HUP0301829A3 (en) 2009-03-30
US20090162367A1 (en) 2009-06-25
RU2004103555A (ru) 2005-07-20
US20110086034A1 (en) 2011-04-14
CN1354755B (zh) 2010-06-02
WO2000031235A3 (en) 2000-11-09
EP2093294A1 (en) 2009-08-26
NZ511683A (en) 2004-06-25
KR100728405B1 (ko) 2007-06-13
RU2358982C2 (ru) 2009-06-20
EP1124846A2 (en) 2001-08-22
IL142989A0 (en) 2002-04-21
RU2304585C2 (ru) 2007-08-20
PT1124846E (pt) 2009-10-08
IL198027A (en) 2011-10-31
DK1124846T3 (da) 2009-10-26
RU2432364C2 (ru) 2011-10-27
US20050260616A1 (en) 2005-11-24
ZA200103714B (en) 2004-06-25
AU774367C (en) 2005-04-21
RU2001115705A (ru) 2004-03-10
EP1124846A4 (en) 2002-06-12
AU774367B2 (en) 2004-06-24
WO2000031235A2 (en) 2000-06-02
KR20020003353A (ko) 2002-01-12
DE69941059D1 (de) 2009-08-13
EP2333064A1 (en) 2011-06-15
PL204293B1 (pl) 2009-12-31
MXPA01004598A (es) 2002-04-24
IL142989A (en) 2010-12-30
EP1124846B1 (en) 2009-07-01
CZ20011608A3 (cs) 2001-10-17
NO332460B1 (no) 2012-09-24
CN1354755A (zh) 2002-06-19
TR200700740T2 (tr) 2007-04-24
CZ304224B6 (cs) 2014-01-15
CY1110679T1 (el) 2015-06-10
US7425334B2 (en) 2008-09-16
SK287323B6 (sk) 2010-07-07
PL362990A1 (en) 2004-11-15
EP2093294B1 (en) 2014-10-29
HK1038027A1 (en) 2002-03-01
JP2012213406A (ja) 2012-11-08
JP2003531566A (ja) 2003-10-28

Similar Documents

Publication Publication Date Title
NO20012223L (no) Nukleotid- og proteinsekvenser for NOGO-genene og fremgangsmåter basert derpå
WO2000003685A3 (en) Nitrilase homologs
ATE389016T2 (de) Sirna knockout prüfverfahren und konstrukte
FR2637612B1 (fr) Sequences de nucleotides codant pour une proteine a activite ureasique
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69939553D1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
DK0917571T3 (da) Hidtil ukendt agoutirelateret gen
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE519847T1 (de) Il-17-homologe polypeptide und ihre therapeutische verwendung
DE69841994D1 (de) 32 Humane sekretierte Proteine
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DK1536006T3 (da) Cancerantigener og anvendelse deraf
WO2001062891A3 (en) 207 human secreted proteins
DE60125148D1 (de) Fctrx genannte proteine und dafür kodierende nuklein säure
DE69734644D1 (de) Carboxypeptidasen aus aspergillus oryzae und diese kodierende nukleinsäuren
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
WO2004074460A3 (en) Nucleotide and protein sequences of coc genes and methods based thereon
ATE278011T1 (de) Human dnase ii
WO2003052377A9 (en) 41 human secreted proteins
BR0210835A (pt) Moléculas de agrecanase
WO2002099066A3 (en) 20 human secreted proteins
WO2002057420A3 (en) 50 human secreted proteins
WO2002026931A3 (en) 71 human secreted proteins
WO2000061750A3 (en) TYROSINE KINASE SUBSTRATE (Tks) PROTEINS

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees